Stryker Corporation

New York Stock Exchange
Back to all articles
Slightly Bearish -15

Apollon Wealth Management LLC Trims Position in Stryker Corporation ...

📉 Apollon Wealth Management LLC trimmed its Stryker position by 62.2% in Q1, reducing holdings to 9,787 shares worth $3.2 million.

📈 Wellington Management Group increased its stake by 22.6% in Q4, adding 1.2 million shares valued at $2.28 billion.

📉 Barclays cut its price target from $469 to $394 while maintaining an 'overweight' rating on the stock.

📉 Wells Fargo and JPMorgan Chase both lowered their price targets to $418 and $400 respectively in early May reports.

📉 Stryker reported Q1 EPS of $2.60, missing analyst consensus estimates of $2.98 by $0.38.

💰 The company generated $6.02 billion in quarterly revenue, slightly below the expected $6.34 billion.

📈 Revenue grew 2.6% year-over-year to reach $6.02 billion during the first quarter of fiscal 2026.

💵 Stryker declared a quarterly dividend of $0.88 per share with an ex-dividend date of June 30th.

📉 Corporate insiders sold approximately 323,264 shares worth over $100 million in the last quarter.

🏢 VP M Kathryn Fink sold 5,220 shares for $1.48 million, reducing her personal stake by 28.44%.

👩‍💼 Director Ronda E. Stryker sold 310,000 shares for $96.8 million, lowering her position by 13.87%.

📊 The stock trades at a P/E ratio of 36.44 with a market cap of $120.69 billion and a beta of 0.78.

Bullish Signals
  • Wellington Management Group significantly increased its position by 22.6% in Q4, adding over 1.19 million shares.
  • State Street Corp and Geode Capital Management also boosted their stakes by 2.1% and 0.9% respectively in the fourth quarter.
  • AllianceBernstein L.P. grew its holdings by 13.3% in Q3, adding 741,542 shares to its portfolio.
  • The company maintains a strong balance sheet with a quick ratio of 1.25 and a current ratio of 2.11.
  • Stryker has set forward guidance for FY 2026 EPS between $14.90 and $15.10, suggesting continued growth expectations.
  • The company declared a quarterly dividend of $0.88 per share, providing a 1.1% annualized yield to investors.
Risk Factors
  • Stryker missed Q1 earnings estimates with EPS of $2.60 versus the consensus expectation of $2.98.
  • Quarterly revenue of $6.02 billion fell short of analyst expectations of $6.34 billion.
  • Multiple major analysts including Barclays, Wells Fargo, JPMorgan Chase, and Needham & Company recently lowered their price targets.
  • Corporate insiders sold a total of 323,264 shares worth over $100 million in the last quarter.
  • VP M Kathryn Fink reduced her personal stake by 28.44% through a sale of 5,220 shares.
  • Director Ronda E. Stryker executed a significant sale of 310,000 shares worth $96.8 million.
Full Analysis
Apollon Wealth Management LLC significantly reduced its stake in Stryker Corporation (NYSE:SYK) by 62.2% during the first quarter, selling 16,099 shares to retain a position of 9,787 shares valued at $3,216,000. In contrast, several other major institutional investors increased their holdings in the fourth quarter. Vanguard Group Inc. grew its stake by 0.4% to own 33,907,291 shares worth approximately $11.9 billion, while State Street Corp and Geode Capital Management LLC also lifted their positions by 2.1% and 0.9%, respectively. Wellington Management Group LLP saw the most aggressive growth among these investors, increasing its holdings by 22.6% to own 6,493,276 shares valued at $2.28 billion. Alliancebernstein L.P. also expanded its stake by 13.3% in the third quarter. Collectively, hedge funds and other institutional investors hold 77.09% of the company's stock. Analyst sentiment regarding Stryker remains mixed with recent adjustments to price targets across major financial institutions. William Blair reissued an "outperform" rating on March 5th, while Barclays, Wells Fargo & Company, JPMorgan Chase & Co., and Needham & Company LLC all lowered their price targets in May, ranging from $394.00 to $418.00, though they maintained "overweight" or "buy" ratings. The consensus rating is currently a "Moderate Buy" with an average target price of $395.33 based on sixteen buy ratings and six hold ratings. Despite the positive institutional accumulation, insider activity has been notable; VP M Kathryn Fink sold 5,220 shares for $1.48 million in May, and Director Ronda E. Stryker sold 310,000 shares for $96.79 million on May 26th, representing a 13.87% decrease in her position. Financially, Stryker reported quarterly earnings of $2.60 EPS in the quarter ended April 30th, missing analyst estimates of $2.98 by $0.38. The company generated revenue of $6.02 billion, a 2.6% increase year-over-year but below the expected $6.34 billion. Key financial metrics include a market capitalization of $120.69 billion, a price-to-earnings ratio of 36.44, and a beta of 0.78. The stock recently opened at $314.81, trading between a 52-week low of $281.00 and a high of $404.87. Additionally, the company declared a quarterly dividend of $0.88 per share payable on July 31st to shareholders of record as of June 30th, resulting in an annualized yield of 1.1%. Stryker has set its fiscal year 2026 guidance between 14.900 and 15.100 EPS, while analysts forecast a full-year EPS of 14.98.